Hippocratic AI Acquires Grove AI

January 12, 2026

Hippocratic AI has acquired Grove AI to accelerate its Life Sciences Division, integrating Grove AI's agentic AI platform and team to expand clinical engagement and trial operations capabilities. The move complements Hippocratic AI's Polaris safety architecture and follows its recent $126M Series C, while the company also launched a Life Sciences Executive Advisory Council and a strategic collaboration with BCG.

Buyers
Hippocratic AI
Targets
Grove AI
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.